Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, Ruckhäberle E, Mohrmann S, Häberle L, Ingenwerth M, Abrar DB, Sawicki LM, Breuckmann K, Fendler WP, Herrmann K, Buchbender C, Antoch G, Umutlu L, Kirchner J. Morawitz J, et al. Among authors: bruckmann nm. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):992-1001. doi: 10.1007/s00259-021-05502-0. Epub 2021 Sep 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34476552 Free PMC article.
Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients.
Bruckmann NM, Sawicki LM, Kirchner J, Martin O, Umutlu L, Herrmann K, Fendler W, Bittner AK, Hoffmann O, Mohrmann S, Dietzel F, Ingenwerth M, Schaarschmidt BM, Li Y, Kowall B, Stang A, Antoch G, Buchbender C. Bruckmann NM, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2816-2825. doi: 10.1007/s00259-020-04801-2. Epub 2020 Apr 24. Eur J Nucl Med Mol Imaging. 2020. PMID: 32333068 Free PMC article.
Comparison of 18F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis.
Li Y, Khamou M, Schaarschmidt BM, Umutlu L, Forsting M, Demircioglu A, Haubold J, Koch AK, Bruckmann NM, Sawicki LM, Herrmann K, Boone JH, Langhorst J. Li Y, et al. Among authors: bruckmann nm. Br J Radiol. 2020 Aug;93(1112):20200167. doi: 10.1259/bjr.20200167. Epub 2020 Jun 24. Br J Radiol. 2020. PMID: 32579403 Free PMC article. Clinical Trial.
Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?
Martin O, Bruckmann NM, Kirchner J, Ullrich T, Ingenwerth M, Bogner S, Eze C, Nensa F, Herrmann K, Umutlu L, Antoch G, Sawicki LM. Martin O, et al. Among authors: bruckmann nm. J Med Imaging Radiat Oncol. 2020 Dec;64(6):779-786. doi: 10.1111/1754-9485.13087. Epub 2020 Jul 24. J Med Imaging Radiat Oncol. 2020. PMID: 32705779
Evaluation of 18F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion.
Chodyla M, Demircioglu A, Schaarschmidt BM, Bertram S, Bruckmann NM, Haferkamp J, Li Y, Bauer S, Podleska L, Rischpler C, Forsting M, Herrmann K, Umutlu L, Grueneisen J. Chodyla M, et al. Among authors: bruckmann nm. J Nucl Med. 2021 Mar;62(3):348-353. doi: 10.2967/jnumed.120.248260. Epub 2020 Jul 31. J Nucl Med. 2021. PMID: 32737246 Free article. Clinical Trial.
Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis: A Prospective Study.
Langhorst J, Umutlu L, Schaarschmidt BM, Grueneisen J, Demircioglu A, Forsting M, Beiderwellen K, Haubold J, Theysohn JM, Koch AK, Dobos G, Dechêne A, Herrmann K, Bruckmann NM, Lauenstein T, Li Y. Langhorst J, et al. Among authors: bruckmann nm. J Clin Med. 2020 Aug 1;9(8):2474. doi: 10.3390/jcm9082474. J Clin Med. 2020. PMID: 32752196 Free PMC article.
Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using 18F-FDG PET/MRI.
Bruckmann NM, Kirchner J, Grueneisen J, Li Y, McCutcheon A, Aigner C, Rischpler C, Sawicki LM, Herrmann K, Umutlu L, Schaarschmidt BM. Bruckmann NM, et al. Eur J Radiol. 2021 Jan;134:109422. doi: 10.1016/j.ejrad.2020.109422. Epub 2020 Nov 19. Eur J Radiol. 2021. PMID: 33271432
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer.
Morawitz J, Kirchner J, Martin O, Bruckmann NM, Dietzel F, Li Y, Rischpler C, Herrmann K, Umutlu L, Bittner AK, Mohrmann S, Ingenwerth M, Häberle L, Esposito I, Antoch G, Buchbender C, Sawicki LM. Morawitz J, et al. Among authors: bruckmann nm. Clin Nucl Med. 2021 Mar 1;46(3):201-205. doi: 10.1097/RLU.0000000000003488. Clin Nucl Med. 2021. PMID: 33351505
PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications.
Morawitz J, Kirchner J, Lakes J, Bruckmann NM, Mamlins E, Hiester A, Aissa J, Loberg C, Schimmöller L, Arsov C, Antke C, Albers P, Antoch G, Sawicki LM. Morawitz J, et al. Among authors: bruckmann nm. Eur J Radiol. 2021 Mar;136:109556. doi: 10.1016/j.ejrad.2021.109556. Epub 2021 Jan 16. Eur J Radiol. 2021. PMID: 33485127
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid 68Ga-DOTATOC PET/MRI.
Bruckmann NM, Rischpler C, Kirchner J, Umutlu L, Herrmann K, Ingenwerth M, Theurer S, Lahner H, Antoch G, Sawicki LM. Bruckmann NM, et al. Eur J Radiol. 2021 Apr;137:109588. doi: 10.1016/j.ejrad.2021.109588. Epub 2021 Feb 19. Eur J Radiol. 2021. PMID: 33639542
35 results